| Literature DB >> 31694203 |
Di Meng1, Liyuan Zhang1, Jie Meng2, Qiaopeng Tian1, Lixin Zhai1, Zhikui Hao3, Zhengbing Guan1, Yujie Cai1, Xiangru Liao1.
Abstract
Phoxim, a type of organophosphorus pesticide (OP), is widely used in both agriculture and fisheries. The persistence of phoxim has caused serious environmental pollution problems. In this study, Bacillus amyloliquefaciens YP6 (YP6), which is capable of promoting plant growth and degrading broad-spectrum OPs, was used to study phoxim degradation. Different culture media were applied to evaluate the growth and phoxim degradation of YP6. YP6 can grow rapidly and degrade phoxim efficiently in Luria-Bertani broth (LB broth) medium. Furthermore, it can also utilize phoxim as the sole phosphorus source in a mineral salt medium. Response surface methodology was performed to optimize the degradation conditions of phoxim by YP6 in LB broth medium. The optimum biodegradation conditions were 40 °C, pH 7.20, and an inoculum size of 4.17% (v/v). The phoxim metabolites, O,O-diethylthiophosphoric ester, phoxom, and α-cyanobenzylideneaminooxy phosphonic acid, were confirmed by liquid chromatography-mass spectrometry. Meanwhile, transcriptome analysis and qRT-PCR were performed to give insight into the phoxim-stress response at the transcriptome level. The hydrolase-, oxidase-, and NADPH-cytochrome P450 reductase-encoding genes were significantly upregulated for phoxim hydrolysis, sulfoxidation, and o-dealkylation. Furthermore, the phoxim biodegradation pathways by YP6 were proposed, for the first time, based on transcriptomic data and product analysis.Entities:
Keywords: Bacillus amyloliquefaciens YP6; degradation pathway; organophosphorus pesticides; phoxim; response surface methodology; transcriptome analysis
Mesh:
Substances:
Year: 2019 PMID: 31694203 PMCID: PMC6864786 DOI: 10.3390/molecules24213997
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The growth and phoxim degradation of strain YP6 in different culture media. (a) The growth and phoxim degradation of strain YP6 in an LB broth medium (containing an initial concentration of 50 mg L−1 phoxim); (b) the growth and phoxim degradation of strain YP6 in an M-2 medium (containing an initial concentration of 50 mg L−1 phoxim). The bars represent the standard errors of assays performed in triplicate.
Random experimental design and results based on response surface methodology (RSM) for phoxim degradation.
| Run | A (Temperature, °C) | B (pH) | C (Initial Inoculum, | R1 (Degradation, %) |
|---|---|---|---|---|
| 1 | 30 | 5 | 5 | 74.9 ± 0.5 |
| 2 | 40 | 7 | 5 | 95.3 ± 0.2 |
| 3 | 30 | 7 | 3 | 85.6 ± 1.1 |
| 4 | 30 | 9 | 1 | 76.0 ± 0.4 |
| 5 | 40 | 5 | 3 | 86.8 ± 0.9 |
| 6 | 30 | 7 | 3 | 85.1 ± 1.4 |
| 7 | 30 | 7 | 3 | 84.6 ± 0.6 |
| 8 | 30 | 5 | 1 | 73.0 ± 0.5 |
| 9 | 40 | 7 | 1 | 92.4 ± 0.3 |
| 10 | 30 | 7 | 3 | 85.5 ± 0.5 |
| 11 | 20 | 9 | 3 | 67.1 ± 0.2 |
| 12 | 20 | 7 | 1 | 73.7 ± 0.7 |
| 13 | 30 | 9 | 5 | 78.6 ± 0.8 |
| 14 | 30 | 7 | 3 | 85.6 ± 1.3 |
| 15 | 20 | 7 | 5 | 71.4 ± 0.4 |
| 16 | 40 | 9 | 3 | 89.4 ± 0.7 |
| 17 | 20 | 5 | 3 | 64.3 ± 0.9 |
ANOVA results of quadratic model.
| Source | Sum of Squares | Freedom | Mean Square | |||
|---|---|---|---|---|---|---|
| Model | 1273.56 | 9 | 141.51 | 285.83 | <0.0001 | significant |
| A | 954.84 | 1 | 954.84 | 1928.70 | <0.0001 | |
| B | 18.30 | 1 | 18.30 | 36.97 | 0.0005 | |
| C | 3.25 | 1 | 3.25 | 6.57 | 0.0374 | |
| AB | 0.01 | 1 | 0.01 | 0.02 | 0.8910 | |
| AC | 6.76 | 1 | 6.76 | 13.65 | 0.0077 | |
| BC | 0.12 | 1 | 0.12 | 0.25 | 0.6341 | |
| A2 | 0.68 | 1 | 0.68 | 1.38 | 0.2789 | |
| B2 | 267.96 | 1 | 267.96 | 541.26 | <0.0001 | |
| C2 | 11.85 | 1 | 11.85 | 23.93 | 0.0018 | |
| Residual | 3.47 | 7 | 0.50 | |||
| Lack of Fit | 2.72 | 3 | 0.91 | 4.84 | 0.0808 | not significant |
| Pure error | 0.75 | 4 | 0.19 | |||
| Cor Total | 1277.02 | 16 |
Note: R2 = 0.9973; Adj R2 = 0.9938.
Figure 2HPLC analysis of metabolic products of phoxim degraded by strain YP6. (a) Extract obtained from a culture of YP6 grown on LB broth plus 50 mg L−1 phoxim for 48 h; (b) extract obtained from an equivalent medium incubated without YP6 for 48 h.
Figure 3Mass spectra of the metabolic products of phoxim degradation by strain YP6. (a) Phoxim; (b) O,O-diethylthiophosphoric ester; (c) phoxom; (d) α-cyanobenzylideneaminooxy phosphonic acid.
Upregulated genes related to phoxim biodegradation in B. amyloliquefaciens YP6.
| Annotation | Gene ID | Gene Length (bp) | Log2 Ratio | False Discovery Rate (FDR) | KEGG | GO | |
|---|---|---|---|---|---|---|---|
| Alkaline phosphatase | gene2812 | 1704 | 3.3402 | 8.19 × 10−6 | 9.52 × 10−5 | - | Catalytic activity |
| Alkaline phosphatase | gene0296 | 1752 | 2.3702 | 0.001386 | 0.006986 | Aminobenzoate degradation… | Catalytic activity, cellular process, metabolic process |
| Hydrolase | gene3280 | 822 | 2.5297 | 0.001637 | 0.007887 | - | Metabolic process, hydrolase activity |
| Hydrolase | gene3724 | 681 | 2.6083 | 0.002753 | 0.011817 | - | Catalytic activity, membrane, membrane part, cellular process, metabolic process, single-organism process |
| Hydrolase | gene0396 | 1152 | 2.0757 | 0.004794 | 0.01811 | - | Catalytic activity, metabolic process |
| Esterase | gene1642 | 780 | 2.0589 | 0.017248 | 0.048692 | - | Catalytic activity, cellular process, metabolic process, single-organism process |
| Aldehyde dehydrogenase | gene4167 | 1338 | 1.7844 | 0.017696 | 0.049755 | Chloroalkane and chloroalkene degradation…, | |
| Monooxygenase | gene0949 | 1137 | 2.5757 | 0.000289 | 0.002002 | … | Catalytic activity, metabolic process, single-organism process |
| Monooxygenase | gene0391 | 1323 | 2.3294 | 0.002035 | 0.009346 | - | Catalytic activity, metabolic process, single-organism process |
| Monooxygenase | gene3517 | 1329 | 2.0024 | 0.005881 | 0.021023 | - | Catalytic activity, metabolic process, single-organism process |
| NADPH-cytochrome P450 reductase | gene0765 | 3186 | 1.6887 | 0.014603 | 0.042848 | Aminobenzoate degradation… | Catalytic activity, binding, metabolic process, single-organism process |
| Glycosyltransferase | gene3605 | 843 | 3.5212 | 1.86 × 10−5 | 0.000197 | - | Catalytic activity |
| Glycosyltransferase | gene3602 | 1038 | 3.6099 | 0.000124 | 0.000985 | - | Catalytic activity |
| Glycosyltransferase | gene3604 | 1137 | 2.9008 | 0.000162 | 0.001233 | - | Catalytic activity |
| Glycosyltransferase | gene1749 | 1704 | 2.6475 | 0.000421 | 0.002651 | - | Catalytic activity |
| Glycosyltransferase | gene3606 | 1140 | 2.3595 | 0.001376 | 0.006966 | - | Catalytic activity |
| Glycosyltransferase | gene3242 | 846 | 2.3983 | 0.002447 | 0.010743 | - | Catalytic activity |
| Glycosyltransferase | gene0462 | 1263 | 1.8593 | 0.012085 | 0.037201 | - | Catalytic activity, membrane, membrane part |
| Glycosyltransferase | gene3982 | 807 | 2.1159 | 0.012498 | 0.038173 | - | Catalytic activity |
| Glycosyltransferase | gene3600 | 1035 | 2.1363 | 0.012623 | 0.038501 | - | Catalytic activity |
“…” contain other pathway; “-” Not matched to KEGG.
Figure 4Differentially expressed genes (DEGs) involved in phoxim determined by qRT-PCR. Black and gray bars represent expression in samples without and with phoxim, respectively. The absolute expression levels are shown with the 16S rRNA used as an endogenous control. Statistically significant differences are marked with * (p-value < 0.05), ** (p-value < 0.01), or *** (p-value < 0.001) using Student’s t-Test.
Figure 5Proposed metabolic pathway of phoxim by strain YP6.